CENPF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.605390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.935000E-01
Normal-vs-Stage2
1.353590E-01
Normal-vs-Stage3
4.863000E-01
Normal-vs-Stage4
2.414400E-01
Stage1-vs-Stage2
6.077600E-01
Stage1-vs-Stage3
6.449400E-01
Stage1-vs-Stage4
6.895600E-01
Stage2-vs-Stage3
3.363800E-01
Stage2-vs-Stage4
9.110600E-01
Stage3-vs-Stage4
4.618200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.658020E-01
Normal-vs-AfricanAmerican
2.210400E-01
Normal-vs-Asian
1.366170E-01
Caucasian-vs-AfricanAmerican
7.855600E-01
Caucasian-vs-Asian
7.985800E-01
AfricanAmerican-vs-Asian
9.319200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.510000E-01
Normal-vs-Female
1.796780E-01
Male-vs-Female
9.885400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.893600E-01
Normal-vs-Age(41-60Yrs)
1.422560E-01
Normal-vs-Age(61-80Yrs)
1.628030E-01
Normal-vs-Age(81-100Yrs)
1.957010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.468200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.677420E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.044200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.937000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.718600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.802600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.287800E-01
Normal-vs-Daily Drinker
2.633400E-01
Normal-vs-Weekly Drinker
2.124800E-01
Normal-vs-Occasional Drinker
1.456820E-01
Normal-vs-Social Drinker
1.462960E-01
Non Drinker-vs-Daily Drinker
4.743000E-01
Non Drinker-vs-Weekly Drinker
7.309600E-01
Non Drinker-vs-Occasional Drinker
6.190800E-01
Non Drinker-vs-Social Drinker
8.477200E-01
Daily Drinker-vs-Weekly Drinker
3.385600E-01
Daily Drinker-vs-Occasional Drinker
2.346200E-01
Daily Drinker-vs-Social Drinker
6.141600E-01
Weekly Drinker-vs-Occasional Drinker
9.285200E-01
Weekly Drinker-vs-Social Drinker
6.165200E-01
Occasional Drinker-vs-Social Drinker
5.041200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.383800E-01
Normal-vs-Grade 2
7.702600E-01
Normal-vs-Grade 3
8.194800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.631300E-04
Grade 1-vs-Grade 3
4.41020000000458E-05
Grade 1-vs-Grade 4
6.383800E-01
Grade 2-vs-Grade 3
2.413600E-01
Grade 2-vs-Grade 4
7.702600E-01
Grade 3-vs-Grade 4
8.194800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.674200E-01
Normal-vs-NonDiabetic
1.259170E-01
Diabetic-vs-NonDiabetic
8.995500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.085900E-02
Normal-vs-NoPancreatitis
1.958400E-01
Pancreatitis-vs-NoPancreatitis
3.426600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.269220E-01
Normal-vs-N1
1.598220E-01
N0-vs-N1
9.250800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.493880E-02
Normal-vs-TP53-NonMutant
1.867240E-01
TP53-Mutant-vs-TP53-NonMutant
9.93030002671702E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
